Drug Chatter -- Tracking biopharma stock chatter

💊 Get Daily Updates on Generic Entry, Litigation, Biosimilars, and More…

Profile for GlycoMimetics, Inc. (GLYC)

« Back to company index

GLYC Chatter Timeline

Stock Ticker for GLYC

Most Active Tweeters for GLYC

UserTweets
@FlashAlert_me 5
@InsiderAlerts4U 5
@Tickeron 4
@BlueBioNow 3
@newsfilterio 3

Recent Tweets for GLYC

Tickeron @Tickeron
$GLYC in Uptrend: 50-day Moving Average moved above 200-day Moving Average on November 17, 2020. View odds for this… https://t.co/9lliMbZlHY
2:01am
InsiderAlerts4U @InsiderAlerts4U
$GLYC: New Insider Filing on GLYCOMIMETICS INC's SVP of Research, CSO JOHN L. MAGNANI: https://t.co/9IkJsXhHFo
January 23rd 2021, 5:01am
newsfilterio @newsfilterio
96,250 shares acquired by King Rachel K. (President, CEO), reported in a new form 4 filed with the SEC $GLYC https://t.co/wY17ccRRYi
January 23rd 2021, 4:01am
newsfilterio @newsfilterio
34,500 shares acquired by Magnani John L. (SVP of Research, CSO), reported in a new form 4 filed with the SEC $GLYC https://t.co/TrB753M6fd
January 23rd 2021, 4:01am
newsfilterio @newsfilterio
34,500 shares acquired by Hahn Brian M. (SVP Finance, CFO), reported in a new form 4 filed with the SEC $GLYC https://t.co/O8KTYoBWO0
January 23rd 2021, 3:01am
InsiderAlerts4U @InsiderAlerts4U
$GLYC: New Insider Filing on GLYCOMIMETICS INC's SVP, Chief Business Officer ARMAND GIRARD: https://t.co/VqqwWWnqRt
January 22nd 2021, 11:01pm
InsiderAlerts4U @InsiderAlerts4U
$GLYC: New Insider Filing on GLYCOMIMETICS INC's SVP Clinical Development, CMO HELEN M. THACKRAY: https://t.co/IKwNUo3qMH
January 22nd 2021, 9:01pm
InsiderAlerts4U @InsiderAlerts4U
$GLYC: New Insider Filing on GLYCOMIMETICS INC's SVP Finance, CFO BRIAN M. HAHN: https://t.co/bA0WJsxaaM
January 22nd 2021, 9:01pm
InsiderAlerts4U @InsiderAlerts4U
$GLYC: New Insider Filing on GLYCOMIMETICS INC's President, CEO RACHEL K. KING: https://t.co/mBlRNzleGb
January 22nd 2021, 9:01pm
FlashAlert_me @FlashAlert_me
$GLYC [15s. delayed] filed SEC form 4: SVP, Chief Business Officer Girard Armand: Granted 25,000 of Common Stock a… https://t.co/1Ti2Bxyqoh
January 22nd 2021, 9:01pm
FlashAlert_me @FlashAlert_me
$GLYC [15s. delayed] filed SEC form 4: SVP Finance, CFO Hahn Brian M.: Granted 34,500 of Common Stock at price $0… https://t.co/tgHKFnXEej
January 22nd 2021, 9:01pm
FlashAlert_me @FlashAlert_me
$GLYC [15s. delayed] filed SEC form 4: SVP Clinical Development, CMO Thackray Helen M.: Granted 34,500 of Common S… https://t.co/VEcawjOKm5
January 22nd 2021, 9:01pm
FlashAlert_me @FlashAlert_me
$GLYC [15s. delayed] filed SEC form 4: SVP of Research, CSO Magnani John L.: Granted 34,500 of Common Stock at pri… https://t.co/yJPSEN1HEs
January 22nd 2021, 9:01pm
FlashAlert_me @FlashAlert_me
$GLYC [15s. delayed] filed SEC form 4: President, CEO King Rachel K.: Granted 96,250 of Common Stock at price $0 o… https://t.co/4IXzCHvcvq
January 22nd 2021, 9:01pm
Tickeron @Tickeron
$GLYC's in Downtrend: Moving Average Convergence Divergence (MACD) Histogram just turned negative. View odds for th… https://t.co/Z8OU90ZShl
January 21st 2021, 7:01am
BlueBioNow @BlueBioNow
$GLYC price movement 2.39 % https://t.co/XgwQoI5WeD
January 20th 2021, 2:01am
Tickeron @Tickeron
$GLYC in Uptrend: 50-day Moving Average crossed above 200-day Moving Average on November 17, 2020. View odds for th… https://t.co/SzIco4UFO7
January 19th 2021, 8:01pm
ChartMill @ChartMill
$GLYC was analyzed by 5 analysts. The buy consensus is at 92%. So analysts seem to be very confident about $GLYC.… https://t.co/b8E66nmn6T
January 17th 2021, 2:01am
fm23 @fm23
$GLYC https://t.co/PeMpGYMb7g
January 16th 2021, 2:01pm
rmacmillan310 @rmacmillan310
$GLYC holding until $4.24 dollars a share https://t.co/4HAc7KkPtG
January 16th 2021, 3:01am
drndvn34 @drndvn34
RT @offshorehunters: $GLYC longer term chart, range starting to tighten up here, on watch https://t.co/qBsz7suhBN
January 15th 2021, 9:01pm
offshorehunters @offshorehunters
$GLYC longer term chart, range starting to tighten up here, on watch https://t.co/qBsz7suhBN
January 15th 2021, 8:01pm
PMDiChristina @PMDiChristina
$GLYC back again, liking this look https://t.co/To4gqyjWUo
January 15th 2021, 7:01pm
rmacmillan310 @rmacmillan310
$GLYC significant price movement on this stock 4.39 % change recently https://t.co/4HAc7KkPtG
January 15th 2021, 6:01pm
JamieLaceyPR @JamieLaceyPR
Looking forward to hearing $GLYC CEO Rachel King (#client) and other industry leaders during this podcast #biotech https://t.co/NR2uOCgHds
January 15th 2021, 2:01pm
CaseyCaseylive @CaseyCaseylive
$isr received FDA approval last week. $glyc will get it in the coming weeks for their drugs treating AML. Similar p… https://t.co/ocnLvXgzpA
January 15th 2021, 1:01am
mediasentiment @mediasentiment
$GLYC new alert at https://t.co/A7qrDarJHY #stocks #daytrading #NYSE #NASDAQ #market 970
January 12th 2021, 11:01pm
grahm_drake @grahm_drake
@BuyerHigh $Glyc ?
January 12th 2021, 8:01pm
BlueBioNow @BlueBioNow
$GLYC definitely going to finish under $3.40 -2.07 % change recently https://t.co/XgwQoI5WeD
January 11th 2021, 6:01pm
mediasentiment @mediasentiment
$GLYC new alert at https://t.co/A7qrDarJHY #stocks #daytrading #NYSE #NASDAQ #market 328
January 11th 2021, 11:01am
mediasentiment @mediasentiment
$GLYC new alert at https://t.co/A7qrDarJHY #stocks #daytrading #NYSE #NASDAQ #market 327
January 11th 2021, 11:01am
Tickeron @Tickeron
$GLYC in Downtrend: its price expected to drop as it breaks its higher Bollinger Band on December 21, 2020. View od… https://t.co/mR0sXhM204
January 11th 2021, 11:01am
gcassidy718 @gcassidy718
$GLYC Looking worse than ever. -2.07 % change recently https://t.co/OpTFVD2XBu
January 11th 2021, 10:01am
BlueBioNow @BlueBioNow
$GLYC Holding this one for the long haul. -2.07 % https://t.co/XgwQoI5WeD
January 11th 2021, 12:01am
GeorgeB14941177 @GeorgeB14941177
RT @mesuterturk: Compared to an average industry price book ratio of 4.55, $GLYC is valued rather cheaply. On top of this, it is cheaper th…
January 10th 2021, 3:01pm
mesuterturk @mesuterturk
Compared to an average industry price book ratio of 4.55, $GLYC is valued rather cheaply. On top of this, it is che… https://t.co/SiAoyrE5Wo
January 10th 2021, 1:01pm
gcassidy718 @gcassidy718
$GLYC substantial price changes on this stock -2.07 % https://t.co/OpTFVD2XBu
January 10th 2021, 4:01am
BlueBioNow @BlueBioNow
$GLYC Hoping to exit this position at some point . . . -2.33 % change recently https://t.co/XgwQoI5WeD
January 9th 2021, 8:01pm
neinto5 @neinto5
$GLYC expecting a FPRX kind of move here. recent good news. still in accumulation.
January 9th 2021, 2:01pm
BlueBioNow @BlueBioNow
$GLYC watching closely ... Over $4.25 this rips 4.32 % change recently https://t.co/XgwQoI5WeD
January 9th 2021, 5:01am
gcassidy718 @gcassidy718
$GLYC "Everything is impossible until someone does it" 4.19 % change recently https://t.co/OpTFVD2XBu
January 8th 2021, 2:01am
tradersreport @tradersreport
RT @Tickeron: $GLYC's in Downtrend: Moving Average Convergence Divergence (MACD) Histogram just turned negative. View odds for this and oth…
January 7th 2021, 9:01pm
Tickeron @Tickeron
$GLYC's in Downtrend: Moving Average Convergence Divergence (MACD) Histogram just turned negative. View odds for th… https://t.co/tWq6N0lrQ7
January 7th 2021, 9:01pm
SmallCapsDaily @SmallCapsDaily
$GLYC APL-106 (uproleselan) Granted Breakthrough Therapy Designation in China for the Treatment of Acute Myeloid Le… https://t.co/WVtDk1zaD4
January 7th 2021, 3:01pm
MarcJacksonLA @MarcJacksonLA
$GLYC APL-106 (uproleselan) Granted Breakthrough Therapy Designation in China for the Treatment of Acute Myeloid Le… https://t.co/YhQcV8bPLP
January 7th 2021, 11:01am
Gambiste1 @Gambiste1
RT @RVH_Investing: $GLYC APL-106 Granted Breakthrough Therapy Designation in China for the Treatment of Acute Myeloid Leukemia
January 7th 2021, 10:01am
Gambiste1 @Gambiste1
RT @IOInvestors: $GLYC +4.9% (announced APL-106 has been granted Breakthrough Therapy Designation from the China NMPA Center for Drug Evalu…
January 7th 2021, 9:01am
Briefingcom @Briefingcom
$GLYC: GlycoMimetics announced APL-106 has been granted Breakthrough Therapy Designation from the China NMPA Center… https://t.co/dSB5xh2RPF
January 7th 2021, 9:01am
RVH_Investing @RVH_Investing
$GLYC APL-106 Granted Breakthrough Therapy Designation in China for the Treatment of Acute Myeloid Leukemia
January 7th 2021, 9:01am
IOInvestors @IOInvestors
$GLYC +4.9% (announced APL-106 has been granted Breakthrough Therapy Designation from the China NMPA Center for Dru… https://t.co/NRbotYEuRg
January 7th 2021, 9:01am

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2021. All rights reserved.